Genetic products maker Affymetrix (NASDAQ:AFFX) recently announced that it has agreed to acquire privately-held eBioscience, a global leader in immunology and oncology flow cytometry reagents, in a deal worth $330 million.
San Diego, California-based eBioscience offers a vast selection of antibodies, enzyme-linked immunosorbent assays (ELISAs) and proteins for life science research and diagnostics. It is an industry leader in flow cytometry (a technique for analysing microscopic particles) and … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards